Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BRTX
#4517
BioRestorative Therapies, Inc. - Common Stock
0.4
8
USD
0.00%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
0.00%
Monthly Change
+128.57%
6 month change
-57.52%
Year Change
-73.03%
Previous Close
0.4
8
Open
0.4
8
Low
0.4
8
High
0.4
8
Volume
3
Markets
US Stock Market
Healthcare
BRTX
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
793.99 K
3.63 M
3.77 M
6.77 M
7.5 M
25.48 M
25.48 M
Valuation ratios
Enterprise value
—
-4.98 M
8.59 M
10.77 M
10.2 M
28.44 M
2.29 M
Price to earnings ratio
—
—
-0.53
-0.5
-1.23
-0.74
-0.2
Price to sales ratio
—
—
74.86
10.39
10.92
16.88
3.65
Price to cash flow ratio
—
—
-1.68
-1.13
-1.35
-0.98
-0.19
Price to book ratio
—
—
0.62
0.63
1.3
29.62
0.21
Enterprise value to EBITDA ratio
—
0.19
-0.46
-0.74
-0.95
-1.87
—
Profitability ratios
Return on assets %
-2.59
-1.97
-1.13
-1.14
-0.73
-3.49
-0.46
Return on equity %
8.47
-2.05
-1.17
-1.25
-1.05
-39.92
-0.71
Return on invested capital %
-189.63
-8 480.11
-5 650.29
-4 304.15
-1 834.18
-3 979.45
—
Gross margin %
100
100
100
100
36.67
53.66
68.13
Operating margin %
-3 574.12
-57.19 K
-14.43 K
-2 180.34
-1 136.12
-2 499.91
-14.61 K
EBITDA margin %
-3 416.48
-57 K
-14.33 K
-2 077.48
-1 056.96
-2 423.83
—
Net margin %
-14.64 K
-96.31 K
-14.07 K
-2 064.98
-882.86
-2 275.41
-9 298.25
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
3.05
59.01
34.36
10.71
2.97
0.84
2.35
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.03
0
0.01
0.05
0.08
0.15
0.01
Solvency ratios
Debt to assets ratio
0.98
0.01
0
—
—
—
—
Debt to equity ratio
-3.21
0.01
0
—
—
—
—
Long term debt to total assets ratio
-1.23
0.01
0
0
—
—
—
Long term debt to total equity ratio
4.03
0.01
0
0
—
—
—
Per share metrics
Operating cash flow per share
—
—
-1.62
-1.52
-1.06
-1.2
-1.11
EBIT per share
—
—
-5.24
-3.48
-1.41
-1.71
-1.38
EBITDA per share
—
—
-5.21
-3.44
-1.38
-1.69
—
Total debt per share
—
—
0
—
—
—
—
Cash per share
—
—
4.08
2.62
1.38
0.33
0.2
Net current asset value per share
—
—
4.18
2.7
1.44
0.35
0.21
Tangible book value per share
—
—
4.15
2.74
1.1
-0.02
0.14
Working capital per share
—
—
4.06
2.45
0.95
-0.07
0.12
Book value per share
—
—
4.37
2.74
1.1
0.04
0.17
News
What Makes Biorestorative Therapies (BRTX) a New Buy Stock
Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Misses Revenue Estimates
Coherus Oncology (CHRS) Reports Q1 Loss, Lags Revenue Estimates
PTC Therapeutics (PTCT) Reports Q1 Loss, Tops Revenue Estimates
Geron (GERN) Reports Q1 Loss, Beats Revenue Estimates
Here's Why Biorestorative Therapies (BRTX) Looks Ripe for Bottom Fishing
Biorestorative Therapies, Inc. (BRTX) Reports Q4 Loss, Lags Revenue Estimates
Absci Corporation (ABSI) Reports Q4 Loss, Misses Revenue Estimates
Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Lag Estimates
Monte Rosa Therapeutics (GLUE) Reports Q4 Loss, Misses Revenue Estimates
BioRestorative Therapies closes $5 million public offering
BioRestorative Therapies earnings beat by $0.05, revenue fell short of estimates